Description: Heramed Limited is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.
Home Page: www.hera-med.com
HMD Technical Analysis
4 Hazoran Street
Netanya,
4250604
Israel
Phone:
61 2 8379 2961
Officers
| Name | Title |
|---|---|
| Mr. David Groberman | Co-Founder, CEO & Exec. Director |
| Mr. Tal Slonim | Co-Founder, COO & Exec. Director |
| Ms. Sivan Sadan | Chief Financial Officer |
| Mr. Michael Nenner | Chief Technology Officer |
| Henry Jordan | Head of Investor Relations |
| Mr. Ariel Laden | VP of Marketing |
| Dr. Josef Tovbin | Chief Medical Officer |
| Mr. Jonathan Hart B.Com., L.L.B. | Company Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 12.4456 |
| Price-to-Sales TTM: | 159.4609 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |